Show simple item record

dc.contributor.authorHopkins, Ella
dc.contributor.authorGu, Weixi
dc.contributor.authorKobe, Bostjan
dc.contributor.authorColeman, Michael
dc.date.accessioned2021-08-10T23:30:24Z
dc.date.available2021-08-10T23:30:24Z
dc.date.issued2021
dc.identifier.issn2296-889X
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/326474
dc.description.abstractAxon degeneration represents a pathological feature of many neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease where axons die before the neuronal soma, and axonopathies, such as Charcot-Marie-Tooth disease and hereditary spastic paraplegia. Over the last two decades, it has slowly emerged that a central signaling pathway forms the basis of this process in many circumstances. This is an axonal NAD-related signaling mechanism mainly regulated by the two key proteins with opposing roles: the NAD-synthesizing enzyme NMNAT2, and SARM1, a protein with NADase and related activities. The crosstalk between the axon survival factor NMNAT2 and pro-degenerative factor SARM1 has been extensively characterized and plays an essential role in maintaining the axon integrity. This pathway can be activated in necroptosis and in genetic, toxic or metabolic disorders, physical injury and neuroinflammation, all leading to axon pathology. SARM1 is also known to be involved in regulating innate immunity, potentially linking axon degeneration to the response to pathogens and intercellular signaling. Understanding this NAD-related signaling mechanism enhances our understanding of the process of axon degeneration and enables a path to the development of drugs for a wide range of neurodegenerative diseases.
dc.format.mediumElectronic-eCollection
dc.languageeng
dc.publisherFrontiers Media SA
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleA Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity.
dc.typeArticle
prism.publicationDate2021
prism.publicationNameFront Mol Biosci
prism.startingPage703532
prism.volume8
dc.identifier.doi10.17863/CAM.73925
dcterms.dateAccepted2021-06-28
rioxxterms.versionofrecord10.3389/fmolb.2021.703532
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2021-01
dc.contributor.orcidHopkins, Ella [0000-0002-6729-9575]
dc.contributor.orcidColeman, Michael [0000-0002-9354-532X]
dc.identifier.eissn2296-889X
rioxxterms.typeJournal Article/Review
cam.issuedOnline2021-07-08


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International